Are peptides legal in Australia? Research supply, TGA rules and what that means

Peptides are not a single legal category. Some are approved therapeutic goods available on prescription, some are scheduled substances, and many are simply research chemicals with no approved human use in Australia at all.

Supplying and holding peptides for legitimate in-vitro laboratory research is lawful. Supplying them for human consumption, making therapeutic claims about them, or using an unapproved substance in a person is not.

That distinction is the whole of the law here, and it is why every product page on this site is written for laboratory use and carries no dosing protocol or health claim.

The TGA regulates therapeutic goods — anything represented as preventing, diagnosing or treating a condition. A substance becomes a therapeutic good largely through how it is presented and what is claimed about it, not just its chemistry.

The Poisons Standard then places substances into schedules. Many peptides of research interest fall into Schedule 4 (prescription only), which means lawful human supply requires a prescription from an authorised Australian practitioner and a product that has been approved or compounded appropriately.

A number of research peptides are not approved for human use in Australia in any form. They exist in the literature, they can be studied in vitro, and they cannot lawfully be sold for people to use.

Research-use-only is not a disclaimer bolted onto a consumer product. It describes the actual, lawful purpose of supply: material provided for laboratory investigation, with identity and purity documented, and not represented as safe or effective in humans.

In practice that means a compliant Australian supplier will not publish dosing schedules, will not describe results a person might expect, will not use before-and-after imagery, and will not answer 'how much should I take'. If a site does those things, it is representing a therapeutic good.

It also means the buyer carries obligations: handling, storage and disposal in line with your institution's requirements, and no diversion to human use.

Personal importation of prescription-only substances is tightly restricted, and parcels are routinely intercepted by the Australian Border Force. Overseas orders are the most common way Australians lose money on peptides — the material is seized, and there is no recourse.

Buying from stock already held in Australia removes the border entirely. There is no import declaration, no customs risk to you, and no month-long transit that degrades cold-chain material.

Every vial we ship is already in the country, stored under temperature control, and dispatched domestically by express post.

Independent purity testing with a lot-matched Certificate of Analysis, so identity and purity are verifiable rather than asserted.

Research-only framing throughout, with no dosing advice, no therapeutic claims and no human-use marketing.

Australian stock and Australian dispatch, an Australian contact point, and clear terms covering age, purpose of supply and returns.

Cold-chain packaging, because a peptide that has sat at ambient temperature for weeks is not the material the CoA describes.

Materials on this site are supplied strictly for in-vitro laboratory research. They are not therapeutic goods, are not approved by the TGA for human use, and are not supplied for human or veterinary consumption.

Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.

Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.